Blood flow and pO 2 changes after vascular-targeted PDT (V-PDT) or cellular-targeted PDT (C-PDT) using 5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl) bacteriochlorin (F 2 BMet) as photosensitizer, were investigated in DBA/2 mice with S91 Cloudman mouse melanoma, and correlated with long-term tumor responses. F 2 BMet generates both singlet oxygen and hydroxyl radicals under NIR irradiation, which consume oxygen. Partial oxygen pressure was lowered in PDT-treated tumors and this was ascribed both to oxygen consumption during PDT and to fluctuations in oxygen transport after PDT. Similarly, microcirculatory blood flow changes as a result of the disruption of blood vessels due to the treatment. A novel non-invasive approach combining Electron Paramagnetic Resonance oximetry and Laser Doppler blood perfusion measurements allowed longitudinal monitoring of hypoxia and vascular function changes in the same animals, after PDT. C-PDT induced parallel changes in tumor pO 2 and blood flow, i.e., an initial decrease immediately after treatment, followed by a slow increase. In contrast, V-PDT led to a strong and persistent depletion of pO 2 , although the microcirculatory blood flow increased. Strong hypoxia after V-PDT led to a slight increase of VEGF level 24 h after treatment. C-PDT caused a ca. 5-day delay in tumor growth, while V-PDT was much more efficient and led to tumor growth inhibition in 90% of animals. The tumors of 44% of mice treated with V-PDT regressed completely and did not reappear for over one year. In conclusion, mild and transient hypoxia after C-PDT led to intense pO 2 compensatory effects and modest tumor inhibition but strong and persistent local hypoxia after V-PDT caused tumor growth inhibition.
The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy (PDT) 
Introduction
Photodynamic therapy (PDT) is a clinically-approved therapy based on the destruction of neoplastic tissues [1] , selective occlusion of choroidal neovascularization secondary to age related macular degeneration [2] , and potentially useful to treat infection by multi-antibiotic resistant organisms [3] . It involves the use of photosensitizer, molecular oxygen and light of a specific wavelength in order to generate reactive oxygen species (ROS, namely singlet oxygen and hydroxyl radicals) which cause apoptosis, autophagy or necrosis of the treated cells, the closure of the blood vessels and eventually an activation of anti-tumor immune response [4] . Thousands of photosensitizers have been tested in vitro and in vivo but only a few of them managed to reach clinical trials [5, 6] . The simultaneous fulfillment of all of criteria for ideal photosensitizer is extremely difficult, and the heterogeneity of pathologically altered tissues and their different interaction with the photosensitizer are additional challenges that must be addressed by the therapy. Recent advances in PDT suggest that a class of compounds that meet most of the requirements for ideal PDT agents are bacteriochlorin derivatives [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . They are characterized by a very high molar absorption coefficients (ε≥100 000 M -1 cm -1 ) in the therapeutic window and therefore may be effective at lower concentrations and allow for a deeper penetration of light in tissue when compared to porphyrin derivatives. Recently, new synthetic bacteriochlorins attained the photostability, long lifetimes in the excited triplet states and high quantum yields in the generation of ROS, that are desirable for PDT photosensitizers. Moreover, some of them display low dark cytotoxicity, high phototoxicity, amphiphilicity and high accumulation in sensitive organelles such as the endoplasmic reticulum (ER) and mitochondria. In particular, in the family of halogenated sufonamide bacteriochlorins it was possible to identify a photosensitizer, 5,10,15,20-tetrakis(2,6-difluoro-3-Nmethylsulfamoylphenyl)bacteriochlorin (F 2 BMet, illustrated in Scheme 1) that closely matches the properties of an ideal PDT photosensitizer and proved very efficient in vitro and in vivo [23, 24] .
A properly designed photosensitizer may not have the expected therapeutic success if it is not used with an appropriate protocol. For example, PDT exerts a profound effect in the tumor tissue oxygenation level and the generation of ROS during the therapy may lead to depletion of oxygen in the tumor, which may impair the efficacy of the therapy [25, 26] . In order to avoid that oxygen consumption becomes a limiting factor in PDT, various authors proposed the fractionation of light irradiation, with short dark periods (150-200 s), to allow for tissue re-oxygenation [27] [28] [29] [30] . Furthermore, tumor tissue oxygenation exhibits very heterogeneous response to PDT, both spatially in different tumors [31] , and between tumors [32] . For photosensitizers that have the vasculature as the main target [30, 33, 34] , the supply of oxygen to tissue might be limited due to vascular damage resulting from PDT. Occlusion of blood vessels and, in consequence, hypoxia can occur within a few minutes after the beginning of PDT. This effect may be reversible or irreversible, depending on the amount of the photosensitizer present in tissue and applied light dose. Even if vessels stay intact and their function remains unchanged immediately after treatment, irreversible vascular damage and collapse develops within hours, leading to hemorrhage and tissue necrosis. The expected decrease in tumor oxygenation, or increase in hypoxia, was observed in vascular-targeted PDT [27, 30, 35] . On the other hand, when tumor cells are targeted in PDT, limited oxygen consumption can lead to increase in oxygenation due to decrease in metabolic consumption of oxygen by cells [36] . Thus, understanding tumor tissue oxygenation before, during and after PDT is useful to obtain the optimal parameters for therapy, and it has even be suggested that monitoring of PDT-induced changes in tumor oxygenation may be a valuable prognostic indicator [37] . One of the indirect methods of hypoxia detection is assessing the presence of protein associated with, or induced by, hypoxia such as VEGF [38, 39] .
Accurate estimation of hypoxia in vivo remains a challenge, although various methods have been tested in vivo, such as pimonidazole retention or hypoxia-induced protein staining [40] . Remarkably, electron paramagnetic resonance (EPR) oxymetry allows for repetitive and non-invasive oxygen measurements in tumors of living animals [41] [42] [43] [44] . In particular, solid oxymetric microcrystals such as lithium phthalocyanine (LiPc) bring accurate and precise information on oxygen partial pressure in probe surroundings [45] [46] . Likewise, optical methods, e.g. Laser Doppler Perfusion Imaging (LDPI), give access to non-invasive blood flow measurements. LDPI provides information on microcirculation of the surface tissues (up to mm) from the tumor surface and tumor surrounding area. Combining the two methods gives insight into tissue physiology in the local (EPR) and global (LDPI) scale, and provides the grounds to understand the roles of vasculature, microcirculatory blood flow and pO 2 in the outcome of PDT. Scheme 2 illustrates how both techniques were implemented in this study. As both methods are non-invasive, longitudinal studies on hypoxia and vascular function may be performed in the same animals. The goal of this study is to determine pO 2 and blood flow changes after vascular PDT (V-PDT, with a drug-to-light interval of 15 min) and tumor-cell targeted PDT (C-PDT, with a drug-to-light interval of 72 h) using a bacteriochlorin derivative and estimate how they correlate with therapy efficacy. In vivo measurements of pO 2 in the tumor give estimates of the oxygen consumption changes during PDT, as well as of changes in its transport and metabolic consumption after PDT.
Simultaneous measurements of microcirculatory blood flow reveal the disrupted function of blood vessels after PDT. Altogether, these experiments may verify the hypothesis that V-PDT massively destroys tumor vessels and leads to extreme hypoxia within the tumor, whereas tumor-targeted C-PDT preserves the oxygenation level in the tumor. 
Materials and methods

Chemicals
Absorption and fluorescence spectra
UV/VIS absorption spectra were recorded in quartz cuvettes with Shimadzu 2100
spectrophotometer. Fluorescence studies were carried out using a Luminescence
Spectrometer LS 50B (Perkin-Elmer).
Tumor model
S91 Cloudman mouse melanoma cell line (subline I3) was described previously [19] [20] [21] . The cells were grown as monolayers in the RPMI medium, supplemented with 5% fetal calf serum and antibiotics (penicillin, streptomycin) at 37 °C in a humidified atmosphere containing 5% CO 2 , as described elsewhere [47] [48] . 
Animal model and experimental groups
Male DBA/2 mice, implanted with the Cloudman S91 melanoma, were 3-4 months old and about 25 g each. The mice were kept on a standard laboratory diet with free access to drinking water in community cages and a 12 h day/night regime. The animals for other tests, and all the remaining mice were observed for survival and acute effects, such as erythema and edema.
Biodistribution experiments
The i.v. administration of the drug formulation was done when the tumor attained a volume of 30-60 mm 3 in each animal, which usually took 10 days after the inoculation.
The formulation, corresponding to a 2 mg/kg of F 2 BMet, was slowly injected in the tail vein of each animal, and the biodistribution was evaluated at 2 time points after administration: 15 min and 72 h. At the selected time points post injection, the mice were anesthetized with ketamine and xylazine. For each animal, the following organs and tissue samples were collected separately and weighed: tumor, muscle, skin, liver, spleen, kidneys, intestines, heart, lungs and blood. The content of F 2 BMet in the tissue samples was determined by fluorescence measurements. In order to extract the pigments, tissue samples were separately homogenized in 1 ml of ice-cold solution ethanol:DMSO (75:25) during 1 min, using a tissue homogenizer Di25 basic, IKA-Werke, GMBH&Co (Stauten, Germany). The homogenate was centrifuged at 1800g for 1 min at 5 ºC, the supernatant was collected and the pellet was re-extracted 3 more times using the procedure described above, to ensure a complete recovery of the drug. The extracts were pooled and the final volume adjusted to 5 ml. The fluorescence analysis of the extracts was done less than 3 h from the harvest. The samples were excited at 505 nm and the fluorescence spectra were recorded in the range between 600 and 800 nm. The amount of F 2 BMet in the tissues is reported as the average from 5 animals, with the standard error of the mean (SEM).
PDT treatments
When ThorLab 500 mA ACC/APC was used. We selected a low laser fluence rate for this study, 48 mW/cm 2 , which is less than half of that typically used in PDT, to minimize heterogeneous oxygen depletion during the irradiation. A laser power meter (Field MaxII-TO, Coherent, Portland, USA) was used to monitor the light power.
ROS detection
The 3'-p-(aminophenyl)fluorescein (APF), a probe with higher selectivity towards hydroxyl radicals, and Singlet Oxygen Sensor Green® (SOSG), a probe specific for respectively. The wells were always exposed to air and oxygen depletion in the solution is unlikely to occur at the low fluence rate used in this experiment.
Tumor pO 2 measurement
Crystalline oxymetric probe lithium phthalocyanine (LiPc, a gift from Prof. Harold 
Blood perfusion measurements
Laser 
PDT induced edema and erythema in the treated legs
Edema was expressed as tumor volume relative to stage before treatment. Erythema was evaluated on the scale between 0 and 2, with 0 -no erythema, 0.5 -minor, 1 -moderate, 2 -intense erythema.
Processing the samples and VEGF ELISA assay
Whole tumors were isolated 24 h after illumination and stored in liquid nitrogen no longer than 2 days. The samples (17 ± 3 mg) were homogenized (30-times) in 100 µl icecold PBS. An additional 100 µl of ice-cold PBS was added and samples were sonicated for 5 min in room temperature. Homogenized samples were centrifuged at 10,000 rpm for 10 min in 4 °C. The supernatants were collected and concentration of protein was measured by the Bradford method. All samples were stored at -24°C for less than 1 day.
Quantitative sandwich enzyme immunoassay for VEGF (ELISA assay) was performed according to manufactured protocols (R&D, MMV00). In each well 20 µg of total protein was added. Each tumor sample was prepared as duplicate.
Ultrasonography
An ultrasonographic imager Vevo 2100 (VisualSonics, Toronto, Canada) was used for obtaining the images of tumors and localization of LiPc crystals (B-mode). Dopplermode was used to images density of vasculature near oxygen spin probe (0.25 mm radius around LiPc). Vevo 2100 1.2.0 software was employed for tumor and LiPc delineation.
Statistical analysis
Group mean values of pO 2 (Figure 4.1) . A slight increase in pO 2 was later observed in one animal, reaching 10 mmHg in day 4 ( Fig.   4.1A) , but the pO 2 value in the other animal did not recover in the observation time ( Fig.   4.1B) . In contrast, C-PDT led to a transient decrease in pO 2 , lasting usually no more than 3 h, followed by a recovery of pO 2 . In one animal, the tumor tissue pO 2 increased even up to 35 mm Hg (Fig. 4.2D) , which is much higher than the value before PDT. The ultrasonographic images of individual animals show sagittal slices of murine legs with tumor cross section delineated in green and position of oxymetric spin probe LiPc marked in red (Fig. 4A-D . Surprisingly, both protocols led to a strong stimulation of blood flow 2 days after the treatment, which was sustained for two weeks in the case C-PDT.
Results
Spectroscopic properties of F 2 BMet in the administration vehicle
C-PDT, but not V-PDT induced parallel changes in tumor pO 2 and blood flow
A slight reduction in pO 2 was noted immediately after V-PDT, which was partially recovered in the following 24 hours, and then deceased to baseline values (Fig. 5A) . In contrast, blood perfusion decreased in the first 24 h after V-PDT, and then increased from day 2 to day 7, to a value 8 times higher than at day 1.
The mean pO 2 in tumors treated with C-PDT strongly decreased immediately after illumination (from 3 mmHg to 0 mmHg), but then increased up to 12 mmHg at 72 h and remained high. The mean blood flow did not change in the first 24 h after C-PDT, and then gradually increased up to a maximum perfusion 5 times higher on day 9. Both pO 2 and blood flow exhibited similar pattern of changes in C-PDT, namely a pronounced increase after PDT and high values one week after PDT. However, the fast reduction in pO 2 immediately after illumination is not associated with a corresponding blood flow change (Fig. 5B) .
Maximal blood perfusion in tumors was reached 7 to 9 after PDT for both protocols, and was 8 and 5 times higher for V-PDT and C-PDT than for a normal leg, respectively.
Both protocols led to an initial decrease in pO 2 . However, on average, V-PDT decreased pO 2 from 2 to 1 mmHg and maintained pO 2 below 2 mmHg in the first 3 days after PDT, whereas C-PDT depleted pO 2 from 3 to 0.5 mmHg but then it increased up to 12 mmHg in the third day after PDT. Both pO 2 and blood flow control values were changed slightly in the dark (Fig. 5D) , whereas an increase up to 6 mmHg in pO 2 value was observed after illumination ( Fig. 5C ). Figure 6 shows that the VEGF levels were slightly increased in tumors 24 hours after V-PDT, but not after C-PDT. This parallels pO 2 depletion and strong hypoxia in tumor tissue after V-PDT (Fig. 5) . It is worth noticing that distribution of this protein content was skewed in all groups suggesting high heterogeneity in VEGF level. However, in V-PDT group VEGF distribution became normal, indicating more homogenous response.
Vascular targeted PDT enhances VEGF level
Biodistribution of F 2 BMet after 15 min and 72h post injection
The biodistribution of Table 1 . Interestingly, 72 hours after F 2 BMet injection its concentration in tumor increased to more than 5 µg per 1 g of wet tissue and was the highest amount among all studied organs/tissues. The tumor-to-skin (T/S) and tumor-to-muscle (T/M) ratios at this time point are 3.8 and 4.3, respectively. Tumor to surrounding tissues ratios after 15 min and 72 h are collected in Table 2 . Figure 7 shows Kaplan-Meier plot with percentage of animals with local tumor control, i.e. tumor volume less than 400 mm 3 . Half of animals survived until day 10 in controls, day 16 after C-PDT, whereas after V-PDT 50% were still alive on day 47. In this group of animals in 44% of mice tumor regressed and did not reappear for 1 year (the end of observation time). This high photodynamic activity towards very resistant melanoma tumors may be explained by efficient generation of both singlet oxygen and hydroxyl radicals. Fig. 8 shows that F 2 BMet activates both APF and SOSG, but the saturation of the fluorescein signal occurs at a lower light dose than that of the endoperoxide. This is assigned to a faster consumption of APF, which would be consistent with the ability of F 2 BMet to generate both hydroxyl radicals and singlet oxygen under illumination in biological media [23] , that would react with APF to release fluorescein, as opposed to SOSG that reacts selectively with singlet oxygen. The hydroxyl radical is a most cytotoxic species and is expected to be a major contributor to tumor damage in PDT with F 2 BMet.
Photodynamic efficacies after V-PDT and C-PDT
The kinetics of the tumor growth of individual animals is presented in
Supplementary Figure S5 . Some acute reactions to PDT treatment were observed, such as edema and erythema at the illuminated site. Erythema usually appeared on day 2, attained its maximum at day 3, and lasted until day 5-6. Interestingly, erythema was present in fewer animals after V-PDT than after C-PDT (Fig. 9A) . Edema of the leg with the tumor was maximal at 3 h after V-PDT, reaching a volume 30 times higher than before the treatment, and then decreased up the day 4 (Fig. 9B) . The maximal edema in animals treated with C-PDT was 15 times higher than the tumor volume before the treatment at day 1, but significantly smaller than the maximal edema observed with V-PDT ( Figure   9B ). The gradual increase of volume seen in the light control reflects the tumor growth (Fig 8B) . Figure 9C shows changes in relative blood flow after PDT in the region of the vena saphena lateralis. A gradual decrease in blood flow in the first 24 h was seen both after V-PDT and C-PDT. After C-PDT the blood flow returned to the normal level within 3-4 days, whereas after V-PDT the strong inhibition of blood flow was maintained for 4 days and suddenly returned to the normal level on day 5.
Discussion
We have recently shown that when halogenated and sulfonated bacteriochlorins absorb NIR radiation, they generate high amounts of singlet oxygen and superoxide ion radicals and, subsequently, hydrogen peroxide and hydroxyl radicals [12] . The combined effects of singlet oxygen and hydroxyl radical make bacteriochlorins more promising and effective in PDT than the corresponding chlorins [51] [52] . Exchanging sulfonic to sulfonamide groups resulted in an even more significant enhancement of photocytotoxicity in vitro [20] and in vivo [21] . The earlier saturation of the signal generated by APF with respect to that generated by SOSG, shown in Fig. 8 for the same concentrations and fluence rates, is consistent with the generation of large quantities of both singlet oxygen and hydroxyl radicals when F 2 BMet is illuminated, because SOSG reacts only with singlet oxygen but APF can be consumed in reactions with hydroxyl radicals and singlet oxygen. The conditions employed in Fig. 8 are similar to those of in vivo experiments (the same light source, fluence rates and light doses). A recent study comparing V-PDT and C-PDT protocols with F 2 BMet in BALB/C mice with subcutaneously implanted CT26 cancer cells showed that V-PDT could lead to a higher rate of tumor remissions than C-PDT [24] . Fig. 7 shows that V-PDT also leads to better treatment outcome than C-PDT in a different tumor model. In addition to these extensions of previous work, we now report for the first time non-invasive EPR oximetry and LDPI measurements that unravel the underlying reasons for the difference between V-PDT and C-PDT.
Non-invasive measurements of tumor pO 2 (EPR) and microcirculatory blood flow (LDPI) provide complementary views on physiology of the vasculature after treatment.
Moreover, they give information both on the local (tumor area around the LiPc probe) and on the global (superficial microperfusion of the tumor and surrounding areas) scales.
Earlier studies on tumor pO 2 after PDT suggested that different patterns in pO 2 and blood flow could emerge after V-PDT or C-PDT [53] [54] [55] . A strong depletion in pO 2 and blood flow should be expected after V-PDT, whereas C-PDT was anticipated to produce a temporary increase in pO 2 . However, the patterns emerging from our studies are more intricate.
V-PDT is an effective therapeutic approach using an array of photosensitizers [24, 30, 34, 55] . Interestingly, both V-PDT and C-PDT stimulated superficial tumor blood flow when compared with controls ( Fig. 5A-D) . This may be a consequence of either scab healing and/or local inflammation, evidenced by edema and erythema, and it is uncertain whether the increased microcirculation has any effect on tumor growth. Edema was much more pronounced after V-PDT than after C-PDT. The source of interstitial edema might be leakage from vessels or a sign of immune response. Leakage from destroyed vasculature should be expected after V-PDT. However, edema correlated with time-totumor volume of 400 mm 3 for animals treated with C-PDT (data not shown) but not for V-PDT, which suggests that inflammation or low vasculature leakage might have a stimulatory effect on tumor growth. Edema of the tumor leg might disturb the blood perfusion and pO 2 measurements because the larger volume of fluid present in the tissue might lead to larger distances to vessels (almost twice, [56] ). However, minimal blood flow was recorded at 24h after V-PDT while maximal edema was observed at 12h, indicating that edema is not biasing our blood flow measurements. Moreover, blood flow measured in the area of vena saphena lateralis was maintained at very low levels for 4 days, while edema was gradually decreasing. The influence of edema in blood flow measurements after C-PDT cannot be excluded. On the other hand, the stronger erythema observed after C-PDT did not correlate with microcirculatory perfusion and could be a result of inflammation.
Vascular-targeted PDT led to better the long-term tumor response than cellulartargeted PDT. Up to 44% animals showed S91 melanoma tumor regression, lasting at least one year after therapy. V-PDT led to deep and chronic hypoxia, whereas tumortargeted C-PDT caused transient hypoxia, quickly reversed. Figure 10A shows that the pO 2 decrease due to C-PDT correlates with a pO 2 increase in the following 24h. Figure   10B shows a selection of animals where pO 2 level dropped to 0 mmHg at any time after illumination. In this sub-set of data, 80% of the animals treated with V-PDT were cured.
Conclusions
Extremely low pO 2 From a single animal two samples were taken. Statistical significance was tested using
Mann-Whitney U test, * p< 0.05, # p< 0.09. Table 2 . Tumor-to-tissue ratios of F 2 BMet in surrounding tissues such as muscle and skin after the iv administration of 2 mg/kg in the formulation cremophor:ethanol:NaCl 0.9% 
